Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Zongchang ^a,b   Hu, Maolin ^a   Zong, Xiaofen ^a   He, Ying ^a   Wang, Dong ^a   Dai, Lulin ^a   Dong, Min ^a   Zhou, Jun ^a   Cao, Hongbao ^c   Lv, Luxian ^e   Chen, Xiaogang ^a,b,d   Tang, Jinsong ^a,c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d National Clinical Research Center for Metabolic Diseases   (China)

^e XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; GENE DOSAGE; GENETICS; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; MITOCHONDRION; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; STATISTICAL MODEL; TELOMERE; TELOMERE SHORTENING; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; DNA, MITOCHONDRIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GENE DOSAGE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MITOCHONDRIA; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISPERIDONE; SCHIZOPHRENIA; TELOMERE; TELOMERE SHORTENING; YOUNG ADULT;

EID: 84950317514     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18553     Document Type: Article

References (46)

1. Epel, E. S. et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology 31, 277-287 (2006).
2. Farooqui, T. & Farooqui, A. A. Aging: An important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130, 203-215 (2009).
3. Kalyani, R. R. & Egan, J. M. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am 42, 333-347 (2013).
4. Koutsouleris, N. et al. Accelerated brain aging in schizophrenia and beyond: A neuroanatomical marker of psychiatric disorders. Schizophr Bull 40, 1140-1153 (2014).
5. Verhoeven, J. E., Revesz, D., Wolkowitz, O. M. & Penninx, B. W. Cellular aging in depression: Permanent imprint or reversible process?: An overview of the current evidence, mechanistic pathways, and targets for interventions. Bioessays 36, 968-978 (2014).
6. Shay, J. W. Telomerase therapeutics: Telomeres recognized as a DNA damage signal: Commentary re: K. Kraemer et al. antisensemediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003. Clin Cancer Res 9, 3521-3525 (2003).
7. De Lange, T. T-loops and the origin of telomeres. Nat Rev Mol Cell Biol 5, 323-329 (2004).
8. Mathon, N. F. & Lloyd, A. C. Cell senescence and cancer. Nat Rev Cancer 1, 203-213 (2001).
9. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309-1312 (1998).
10. Kowaltowski, A. J., de Souza-Pinto, N. C., Castilho, R. F. & Vercesi, A. E. Mitochondria and reactive oxygen species. Free Radic Biol Med 47, 333-343 (2009).
11. Yakes, F. M. & Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94, 514-519 (1997).
12. Carew, J. S. & Huang, P. Mitochondrial defects in cancer. Mol Cancer 1, 9 (2002).
13. Taylor, R. W. & Turnbull, D. M. Mitochondrial DNA mutations in human disease. Nat Rev Genet 6, 389-402 (2005).
14. Barazzoni, R., Short, K. R. & Nair, K. S. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 275, 3343-3347 (2000).
15. Sahin, E. & DePinho, R. A. Axis of ageing: Telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol 13, 397-404 (2012).
16. Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359-365 (2011).
17. Haendeler, J. et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 29, 929-935 (2009).
18. Kim, J. H., Kim, H. K., Ko, J. H., Bang, H. & Lee, D. C. The Relationship between Leukocyte Mitochondrial DNA Copy Number and Telomere Length in Community-Dwelling Elderly Women. PLoS One 8, e67227 (2013).
19. Tyrka, A. R. et al. Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults. Exp Gerontol 66, 17-20 (2015).
20. Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E. & Bowie, C. R. Is Schizophrenia a Syndrome of Accelerated Aging? Schizophr Bull 34, 1024-1032 (2008).
21. Kao, H. T. et al. Rapid telomere erosion in schizophrenia. Mol Psychiatry 13, 118-119 (2008).
22. Mansour, H. et al. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia? Psychiatry Res 188, 129-132 (2011).
23. Nieratschker, V. et al. Longer telomere length in patients with schizophrenia. Schizophr Res 149, 116-120 (2013).
24. Malaspina, D. et al. Telomere length, family history, and paternal age in schizophrenia. Mol Genet Genomic Med 2, 326-331 (2014).
25. Yu, W. Y., Chang, H. W., Lin, C. H. & Cho, C. L. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J Psychiatry Neurosci 33, 244-247 (2008).
26. Fernandez-Egea, E. et al. Telomere Length and Pulse Pressure in Newly Diagnosed, Antipsychotic-Naive Patients With Nonaffective Psychosis. Schizophr Bull 35, 437-442 (2009).
27. Kakiuchi, C. et al. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 8, 515-522 (2005).
28. Sabunciyan, S. et al. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder. J Neural Transm 114, 665-674 (2007).
29. Torrell, H. et al. Mitochondrial DNA (mtDNA) in brain samples from patients with major psychiatric disorders: Gene expression profiles, mtDNA content and presence of the mtDNA common deletion. Am J Med Genet B Neuropsychiatr Genet 162, 213-223 (2013).
30. Kota, L. N., Purushottam, M., Moily, N. S. & Jain, S. Shortened telomere in unremitted schizophrenia. Psychiatry Clin Neurosci 69, 292-297 (2015).
31. Martinsson, L. et al. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Transl Psychiatry 3, e261 (2013).
32. Somerville, S. M., Lahti, A. C., Conley, R. R. & Roberts, R. C. Mitochondria in the striatum of subjects with schizophrenia: Relationship to treatment response. Synapse 65, 215-224 (2011).
33. Somerville, S. M., Conley, R. R. & Roberts, R. C. Mitochondria in the striatum of subjects with schizophrenia. World J Biol Psychiatry 12, 48-56 (2011).
34. Roberts, R. C., Barksdale, K. A., Roche, J. K. & Lahti, A. C. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophr Res http://dx.doi.org/10.1016/j.schres.2015.1007.1016 [Epub ahead of print] (2015).
35. Uranova, N. et al. The ultrastructure of lymphocytes in schizophrenia. World J Biol Psychiatry 8, 30-37 (2007).
36. Vawter, M. et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry 11, 615-679 (2006).
37. Savolainen, K. et al. History of mental disorders and leukocyte telomere length in late adulthood: The Helsinki Birth Cohort Study (HBCS). J Psychiatr Res 46, 1346-1353 (2012).
38. Epel, E. S. et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101, 17312-17315 (2004).
39. Furukawa, T. A. et al. Initial severity of schizophrenia and efficacy of antipsychotics: Participant-level meta-analysis of 6 placebocontrolled studies. JAMA Psychiatry 72, 14-21 (2015).
40. Maurer, I. & Moller, H. J. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem 174, 255-259 (1997).
41. Balijepalli, S., Kenchappa, R. S., Boyd, M. R. & Ravindranath, V. Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: Comparison with atypical antipsychotics. Neurochem Int 38, 425-435 (2001).
42. Toriumi, K. et al. Effect of antipsychotics on telomere length in the hippocampus. Int J Neuropsychopharmacol 17, 103-103 (2014).
43. Leucht, S., Davis, J. M., Engel, R. R., Kane, J. M. & Wagenpfeil, S. Defining 'response' in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 32, 1903-1910 (2007).
44. Obermeier, M. et al. Should the PANSS be rescaled? Schizophr Bull 36, 455-460 (2010).
45. Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res 30, e47 (2002).
46. Xing, J. et al. Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma. J Natl Cancer Inst 100, 1104-1112 (2008).